Review clinical trials related to Hypochondroplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
Not listed
The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period.
Participants must be 0 to < 36 months of age at randomization. [+3]
Short stature condition other than HCH (eg, ACH, trisomy 21, pseudoachondroplasi... [+10]
The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.
Aged 3 years old or older at the time of consent. [+6]
Subjects who have short stature condition other than ACH/HCH. [+8]
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Participants must be ≤ 15 years old at the time of signing the informed consent [+1]
Have a diagnosis of another genetic short stature condition other than Hypochond... [+1]
This registry is a observational, single-center study designed to collect clinical data on patients with achondroplasia and hypochondroplasia.
Confirmed diagnosis of achondroplasia/hypochondroplasia [+1]
Absence of diagnosis of achondroplasia/hypochondroplasia [+1]